ARTICLE | Distillery Therapeutics
Therapeutics: NLR family pyrin domain containing 3 (NLRP3; NALP3; CIAS1)
April 14, 2016 7:00 AM UTC
Cell culture and mouse studies suggest the NLRP3 inhibitor arglabin could help treat Type II diabetes. In a mouse model of high-fat diet-induced Type II diabetes, arglabin decreased weight, plasma lev...